ClinicalTrials.govpublic full text
Omega-3 Fatty Acids in Sickle Cell Disease
sickle cell disease, omega-3 fatty acids, docosahexaenoic acid (dha), eicosapentaenoic acid (epa), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 844362
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.